Search

Emmanuel Oyekan Dr Akala

from Mitchellville, MD
Age ~73
Get Report
Also known as:
Emmanuel O Akala, Emanuel O Akala, Emmaunuel O Akala, Emmanuel O Okala, Emmanuel O'Akala
Phone and address:
1306 Forest Lake Ct, Bowie, MD 20721
(301) 333-2607
Related to:
Robert Anthony Spencer, 40Norma A Martinez, 48Edgar O Sevilla, 40Sola AdeleyeAlicia Solorzano, 63Bunmi Adeleye
Connected to:
Anthony A Akali, 49Coskun Akalin, 68Florence Akalonu, 75Everett H Akam, 76Randy S Akam, 62Felister V Akama, 41Hiromasa Akamatsu, 50Keisho Akamatsu, 38Tayo Akamo, 70Ekanem Akan, 43

Emmanuel Akala Phones & Addresses

  • 1306 Forest Lake Ct, Bowie, MD 20721 (301) 333-2607
  • 16710 Federal Hill Ct, Bowie, MD 20716
  • Mitchellville, MD
  • Baltimore, MD
  • 7308 Sara St, Hyattsville, MD 20784
  • New Carrollton, MD
  • Salt Lake City, UT
  • Washington, DC
  • Dryden, NY
  • Lilburn, GA
  • 1306 Forest Lake Ct, Mitchellville, MD 20721

Work

Company: Department of pharmaceutical sciences Oct 2013 Position: Member of the advisory group of the center

Education

School / High School: University of Utah 1996 Specialities: Research Associate

Professional Records

License Records

Emmanuel O Akala

Address:
Bowie, MD
License #:
319384-1702 - Expired
Category:
Pharmacy
Issued Date:
Apr 8, 1996
Expiration Date:
Nov 26, 1997
Type:
Pharmacy Intern

Emmanuel O Akala

Address:
Bowie, MD
License #:
319384-1701 - Active
Category:
Pharmacy
Issued Date:
Nov 26, 1997
Expiration Date:
Sep 30, 2017
Type:
Pharmacist

Emmanuel O Akala

Address:
Bowie, MD
License #:
319384-8911 - Expired
Category:
Pharmacy
Issued Date:
Nov 26, 1997
Expiration Date:
May 31, 2001
Type:
Pharmacist Controlled Substance

Emmanuel O. Akala

License #:
PH3236 - Active
Category:
PHARMACY - PROFESSIONAL
Issued Date:
Jun 28, 2011
Expiration Date:
Feb 28, 2019
Type:
VACCINATION AND IMMUNIZATION AGENT

Resumes

Resumes

Emmanuel Akala Photo 1

Emmanuel Akala Mitchellville, MD

View page
Work:
Department of Pharmaceutical Sciences

Oct 2013 to 2000
Member of the Advisory Group of the Center
Department of Pharmaceutical Sciences

Jul 2011 to 2000
Professor of Pharmaceutics
Caremark Floater Pharmacist Part-Time

Oct 1998 to 2000
CVS
Association 2013

Apr 2013 to Apr 2013
Caremark Floater Pharmacist Part-Time
Washington, DC
Jul 2003 to Jul 2011
Associate Professor Department
Department of Pharmaceutical

Jan 1998 to Jun 2003
Assistant Professor
National Institutes of Health Fogarty International
Bethesda, MD
Oct 1994 to Nov 1997
Fellow
Pharmaceutics, Obafemi Awolowo University

1986 to 1994
Lecturer one and then Senior lecturer
DAAD

Sep 1993 to Nov 1993
Fellow
Education:
University of Utah
1996 to 1997
Research Associate
University of Utah
1994 to 1996
Ph.D.
University of Utah
Dec 1995
Pharmacy Foreign Graduate Examination
University of Muenster
1993
Ph.D.
The University of Manchester
1986
Ph.D. in Pharmaceutics
University of Ife
1983
Ph.D. in Pharmaceutics
University of Ife
1980
B.Pharm. in Pharmacy
National Institutes of Health Fogarty International Center
Ph.D. in USA and Research Associate
Department of Pharmaceutics and Pharmaceutical Chemistry/ Center for Controlled Chemical

Publications

Us Patents

Stealth Polymeric Particles For Delivery Of Bioactive Or Diagnostic Agents

View page
US Patent:
20120129798, May 24, 2012
Filed:
Nov 23, 2010
Appl. No.:
12/952856
Inventors:
Emmanuel AKALA - Mitchellville MD, US
Oluyomi Okunola - Beltsville MD, US
International Classification:
A61K 31/337
A61K 31/135
C08F 8/00
A61K 31/704
C08F 265/06
C08F 8/32
US Classification:
514 34, 5253289, 526319, 525380, 525386, 525376, 428402, 514449, 514657
Abstract:
The present invention is directed to a crosslinked or non-crosslinked polymer particle, wherein the crosslinked polymer particle comprises a copolymer of poly(alklyene glycol-graft-acrylate) that is crosslinked by at least one hydrolysable monomer or crosslinking agent. The present invention is also directed to a polymer particle comprising a crosslinked polymer particle that is a product of starting materials comprising (a) a hydrophilic monomer, (b) a hydrophobic monomer, and (c) a hydrolysable crosslinking agent (the crosslinking agent may be absent in the case of non-crosslinked particles). The present invention is still further directed to a polymer particle comprising a crosslinked copolymer, where the crosslinked copolymer includes structures represented by Formulas (I), (II), and (III), as defined in the specification. Other embodiments of the present invention also include methods of manufacturing polymer particles.

Biodegradable Stealth Polymeric Particles Fabricated Using The Macromonomer Approach By Free Radical Dispersion Polymerization

View page
US Patent:
20120129797, May 24, 2012
Filed:
Nov 23, 2010
Appl. No.:
12/952843
Inventors:
Emmanuel AKALA - Mitchellville MD, US
Simeon ADESINA - Lanham MD, US
International Classification:
C08G 63/06
C08G 63/08
C08G 63/60
A61K 31/337
A61K 31/704
A61J 3/00
C08G 63/66
A61P 35/00
B82Y 5/00
US Classification:
514 34, 525450, 525437, 528354, 428402, 514449, 264 4, 977773
Abstract:
The present invention is directed to a crosslinked or non-crosslinked polymer particle, wherein the crosslinked polymer particle comprises a copolymer of poly(alklyene glycol-graft-lactate) that is crosslinked by at least one hydrolysable monmer. Another embodiment of the present invention is a polymer particle comprising a crosslinked polymer particle that is a product of starting materials comprising (a) a hydrophilic monomer, (b) a hydrophobic monomer, and (c) a hydrolysable crosslinking agent. Another embodiment of the present invention is a polymer particle comprising, a crosslinked copolymer comprises structures represented by Formulas (I), (II), and (III), where Formulas (I), (II) and (III) are defined in the specification. Yet other embodiments of the present invention include a method of preparing a methacrylate terminated macromonomer, a method of preparing a crosslinking agent, and a method of preparing a therapeutic agent loaded nanosphere by dispersion polymerization.

Stealth Nanoparticles

View page
US Patent:
20200163884, May 28, 2020
Filed:
Nov 27, 2019
Appl. No.:
16/698297
Inventors:
- Washington DC, US
Emmanuel Oyekanmi Akala - Mitchellville MD, US
Assignee:
HOWARD UNIVERSITY - Washington DC
International Classification:
A61K 9/14
A61P 35/00
A61K 31/395
A61K 31/337
A61K 47/10
A61K 47/18
A61K 47/34
Abstract:
Provided is a method for preparing a drug loaded nanoparticle comprising: dissolving a macromonomer, a stabilizer and a crosslinker in a solvent to create a mixture; adding an initiator system to the mixture; dissolving a drug or combination of drugs in an organic phase containing the mixture; and recovering the drug loaded nanoparticle, a composition comprising the drug loaded nanoparticle prepared by the above method, and a method for treating cancer comprising administering the above composition to a subject in need thereof.

Biodegradable Stealth Polymeric Particles Fabricated Using The Macromonomer Approach By Free Radical Dispersion Polymerization

View page
US Patent:
20170240698, Aug 24, 2017
Filed:
May 9, 2017
Appl. No.:
15/590239
Inventors:
Emmanuel Oyekanmi Akala - Mitchellville MD, US
Simeon Kolawole Adesina - Mitchellville MD, US
Assignee:
Howard University - Washington DC
International Classification:
C08G 63/78
A61K 9/16
C08G 63/06
A61K 31/7034
B01J 13/06
B01J 13/16
C08G 63/82
A61K 31/337
Abstract:
The present invention is directed to a crosslinked or non-crosslinked polymer particle, wherein the crosslinked polymer particle comprises a copolymer of poly(alkylene glycol-graft-lactate) that is crosslinked by at least one hydrolysable monomer. Another embodiment of the present invention is a polymer particle comprising a crosslinked polymer particle that is a product of starting materials comprising (a) a hydrophilic monomer, (b) a hydrophobic monomer, and (c) a hydrolysable crosslinking agent. Another embodiment of the present invention is a polymer particle comprising, a crosslinked copolymer comprising structures represented by Formulas (I), (II), and (III), where Formulas (I), (II) and (III) are defined in the specification. Yet other embodiments of the present invention include a method of preparing a methacrylate terminated macromonomer, a method of preparing a crosslinking agent, and a method of preparing a therapeutic agent loaded nanosphere by dispersion polymerization.
Control profile
Emmanuel Oyekan Dr Akala from Mitchellville, MD, age ~73 Get Report